COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,036 Articles (22,627 medRxiv, 8,409 bioRxiv)

Most recent first Previous |  Page 1483: Articles 14821-14830  | Next

Isolation of SARS-CoV-2 B.1.1.28.2 P2 variant and pathogenicity comparison with D614G variant in hamster model
Yadav, P., Mohandas, S., Sarkale, P., Nyayanit, D., Shete, A., Sahay, R., Potdar, V., Baradkar, S., Gupta, N., Sapkal, G., Abraham, P., Panda, S., Bhargava, B.
10.1101/2021.05.24.445424 — Posted: 2021-05-24
Cooperative multivalent receptor binding promotes exposure of the SARS-CoV-2 fusion machinery core
Pak, A. J., Yu, A., Ke, Z., Briggs, J., Voth, G. A.
10.1101/2021.05.24.445443 — Posted: 2021-05-24
Evidence for Deleterious Original Antigenic Sin in SARS-CoV-2 Immune Response
Sen, S. R., Sanders, E. C., Santos, A. M., Bhuvan, K., Tang, D. Y., Gelston, A. A., Miller, B. M., Ricks-Oddie, J. L., Weiss, G. A.
10.1101/2021.05.21.445201 — Posted: 2021-05-24
Evaluation of mRNA-1273 against SARS-CoV-2 B.1.351 Infection in Nonhuman Primates
Corbett, K. S., Werner, A., O'Connell, S., Gagne, M., Lai, L., Moliva, J., Flynn, B., Choi, A., Koch, M., Foulds, K. E., Andrew, S., Flebbe, D., Lamb, E., Nurmukhambetova, S. T., Provost, S., Bock, K. W., Minai, M., Nagata, B. M., Van Ry, A., Flinchbaugh, Z., Johnston, T. S., Bayat Mokhtari, E., Mudvari, P., Henry, A. R., Laboune, F., Chang, B., Porto, M., Wear, J., Alvarado, G. S., Boyoglu-Barnum, S., Todd, J.-P., Bart, B., Cook, A., Dodson, A., Pessaint, L., Steingrebe, K., Elbashir, S., Andersen, H., Wu, K., Edwards, D. K., Kar, S., Lewis, M. G., Boritz, E., Moore, I., Carfi, A., Suthar, M., McDermott, A., Roederer, M., Nason, M. C., Sullivan, N. J., Douek, D. C., Graham, B. S., Seder, R. A.
10.1101/2021.05.21.445189 — Posted: 2021-05-24
Interplay between protein stability, binding to ACE2 and escape from neutralizing antibodies determines the natural selection of SARS-CoV-2 receptor binding domain variants
Upadhyay, V., Lucas, A., Panja, S., Mallela, K.
10.1101/2021.05.23.445348 — Posted: 2021-05-24
Unsupervised explainable AI for the collective analysis of a massive number of genome sequences: various examples from the small genome of pandemic SARS-CoV-2 to the human genome
Ikemura, T., Iwasaki, Y., Wada, K., Wada, Y., Abe, T.
10.1101/2021.05.23.445371 — Posted: 2021-05-24
The COVID in the Context of Pregnancy, Infancy and Parenting (CoCoPIP) Study: protocol for a longitudinal study of parental mental health, social interactions, physical growth, and cognitive development of infants during the pandemic.
Aydin, E., Weiss, S. M., Glasgow, K. A., Barlow, J., Austin, T., Johnson, M. H., Lloyd-Fox, S.
10.1101/2021.05.22.21257649 — Posted: 2021-05-24
Effectiveness of COVID-19 vaccines against the B.1.617.2 variant
Lopez Bernal, J., Andrews, N., Gower, C., Gallagher, E., Simmons, R., Thelwall, S., Tessier, E., Groves, N., Dabrera, G., Myers, R., Campbell, C., Amirthalingam, G., Edmunds, M., Zambon, M., Brown, K., Hopkins, S., Chand, M., Ramsay, M.
10.1101/2021.05.22.21257658 — Posted: 2021-05-24 Discussion: Onsite | Offsite
Attitudes Toward The COVID-19 Vaccine Among North Carolina Participants In The COVID-19 Community Research Partnership
Enwezor, C., Peacock, J. E., Edelstein, S. L., Hinkelman, A. N., Seals, A. L., Wierzba, T. F., Munawar, I., Runyon, M. S., Magurie, P. D., Lagarde, W. H., Gibbs, M. A., Gallaher, T. R., Sanders, J. W., herrington, d.
10.1101/2021.05.20.21257343 — Posted: 2021-05-24
EVALUATION OF A RAPID ANTIGEN TEST FOR SARS-COV-2 IN SYMPTOMATIC PATIENTS AND THEIR CONTACTS: A MULTICENTER STUDY
THIRION-ROMERO, I., GUERRERO-ZUNIGA, S., ARIAS-MENDOZA, A., CORNEJO-JUAREZ, D. P., MEZA-MENESES, P., TORRES-ERAZO, D. S., Hernandez-Gilsoul, T., Galindo-Fraga, A., Villegas-Mota, I., Sepulveda -Delgado, J., Avila-Rios, S., Becerril-Vargas, E., FERNANDEZ-PLATA, R., Perez-Kawabe, M., Vazquez-Perez, J. A., KAWA-KARASIK, S., REYES-TERAN, G., Perez-Padilla, R.
10.1101/2021.05.24.21257020 — Posted: 2021-05-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).